Target intelligence / Profile preview

Cell turnover enhancer

Molecular classification
Pharmacological class, Functional category, Other
01

Overview

"Cell turnover enhancer" is a functional and pharmacological descriptor rather than a specific molecular target (such as a single receptor or enzyme). It refers to a class of therapeutic and cosmetic agents that accelerate the natural physiological process of desquamation—the shedding of dead corneocytes—and stimulate the mitotic production of new keratinocytes in the basal layer of the epidermis (Mukherjee S, et al., 2006). This process is vital for maintaining skin texture, treating acne, and reversing signs of photoaging. The actual molecular targets mediating these effects vary: retinoids act through nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs) to modulate gene expression related to growth and differentiation (Brattsand M, et al., 2005). Meanwhile, chemical exfoliants like alpha-hydroxy acids (AHAs) function by weakening the ionic bonds between corneocytes or by influencing the activity of endogenous desquamatory enzymes, such as kallikrein-related peptidases (Babilas P, et al., 2012). While these agents are therapeutically significant for conditions like psoriasis and hyperpigmentation, they often carry safety concerns including skin irritation, barrier disruption, and increased sensitivity to ultraviolet radiation.

Other names
Cell renewal agentDesquamating agentExfoliantKeratolytic agentSkin turnover booster
02

Mechanism of action

Activation of Retinoic Acid Receptors (RAR) and Retinoid X Receptors (RXR) to stimulate keratinocyte proliferation and differentiation; enzymatic degradation of desmosomal proteins to facilitate the shedding of the stratum corneum; reduction of corneocyte adhesion through pH-dependent inhibition of ionic bonding.

03

Biological functions

Cell proliferationCell differentiationDesquamationTissue regenerationEpidermal homeostasis
04

Disease associations

Acne vulgarisPhotoagingPsoriasisIchthyosisHyperpigmentationActinic keratosis
05

Safety considerations

Retinoid dermatitisIncreased photosensitivity (UV sensitivity)Skin barrier impairmentErythema and peelingPotential teratogenicity (for systemic retinoids)
06

Interacting drugs

Tretinoin

5 more in the full profile.

07

Biomarkers

Ki-67 expression (proliferation marker)Epidermal thicknessTransepidermal water loss (TEWL)Desmoglein-1 levelsTransglutaminase-1 expression

Beyond the preview

Go deeper on Cell turnover enhancer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell turnover enhancer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call